Professor
Cambridge University
Cambridge, England, United Kingdom
Dr Andreas Bender is a Professor for Molecular Informatics at Cambridge University, working on data analysis methods related to compound safety and efficacy, and Chief Informatics & Technology Officer (CITO) at Pangea Bio, based in London and Berlin. Previously he was a Director for Digital Life Sciences at Nuvisan in Berlin, as well as as an Associate Director for Data Science and AI in the Clinical Pharmacology & Safety Sciences group at AstraZeneca. On the entrepreneurial side, Andreas was involved in setting up Healx Ltd. (for data-driven drug repurposing) and PharmEnable Ltd. (for designing novel chemistry for targets that are difficult to drug conventially), both based in Cambridge/UK. He received his PhD from the University of Cambridge and worked in the Lead Discovery Informatics group at Novartis in Cambridge/MA as well as at Leiden University in the Netherlands before his current post.
Disclosure information not submitted.
AI in Drug Discovery - Approaches, Current Status, and Challenges
Tuesday, May 28, 2024
14:30 – 15:00 CEST